NOVAVAX INC — SC 13G/A Filings
55 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by NOVAVAX INC (NVAX), sorted by most recent first. Each row links to the full filing on EdgarLookup. NOVAVAX INC has filed 55 SC 13G/A documents with the SEC since 2012. To view all SEC filings by NOVAVAX INC, see the full filings list.
All
10-K
10-K/A
10-K405
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B2
424B3
424B5
424B7
425
5
8-A12G
8-K
8-K/A
ARS
CB
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFR14A
DFAN14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PREC14A
PRER14A
REGDEX
S-3
S-3/A
S-3ASR
S-4
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | — | 0000932471-24-001128 | Nov 12, 2024 | — |
| SC 13G/A | — | 0000932471-24-000542 | Nov 4, 2024 | — |
| SC 13G/A | SCHEDULE 13G, AMENDMENT NO. 1 | 0001193125-24-164331 | Jun 20, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021584 | Feb 13, 2024 | — |
| SC 13G/A | — | 0001086364-24-004696 | Jan 26, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-23-016594 | Feb 9, 2023 | — |
| SC 13G/A | — | 0001306550-23-006512 | Feb 1, 2023 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-22-126212 | Dec 12, 2022 | — |
| SC 13G/A | — | 0000834237-22-009120 | Mar 11, 2022 | — |
| SC 13G/A | NOVAVAX INC | 0001104659-22-022786 | Feb 14, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-22-018206 | Feb 10, 2022 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-023874 | Feb 16, 2021 | — |
| SC 13G/A | — | 0000834237-21-007443 | Feb 5, 2021 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-20-018917 | Feb 12, 2020 | — |
| SC 13G/A | — | 0000215457-19-007304 | Feb 11, 2019 | — |
| SC 13G/A | — | 0000932471-18-004393 | Feb 9, 2018 | — |
| SC 13G/A | — | 0000215457-18-005096 | Feb 8, 2018 | — |
| SC 13G/A | — | 0000315066-17-002773 | Sep 11, 2017 | — |
| SC 13G/A | — | 0000315066-17-001906 | Feb 14, 2017 | — |
| SC 13G/A | — | 0000932471-17-001749 | Feb 10, 2017 | — |
| SC 13G/A | — | 0000080255-17-001105 | Feb 7, 2017 | — |
| SC 13G/A | AMENDED SCHEDULE 13G | 0001445546-17-000685 | Jan 31, 2017 | — |
| SC 13G/A | — | 0000353480-17-001507 | Jan 25, 2017 | — |
| SC 13G/A | — | 0000315066-16-006379 | Nov 10, 2016 | — |
| SC 13G/A | — | 0000315066-16-005385 | Feb 12, 2016 | — |
| SC 13G/A | NVAX AS OF 12/31/2015 | 0000080255-16-000918 | Feb 10, 2016 | — |
| SC 13G/A | — | 0000215457-16-003576 | Jan 27, 2016 | — |
| SC 13G/A | SC 13G/A | 0001144204-15-010197 | Feb 17, 2015 | — |
| SC 13G/A | — | 0000315066-15-002156 | Feb 13, 2015 | — |
| SC 13G/A | — | 0001086364-15-001156 | Jan 29, 2015 | — |
| SC 13G/A | SC 13G/A | 0001144204-14-009455 | Feb 14, 2014 | — |
| SC 13G/A | — | 0000315066-14-002347 | Feb 14, 2014 | — |
| SC 13G/A | — | 0001086364-14-001295 | Jan 30, 2014 | — |
| SC 13G/A | SC 13G/A | 0001144204-13-009020 | Feb 14, 2013 | — |
| SC 13G/A | — | 0000315066-13-002988 | Feb 14, 2013 | — |
| SC 13G/A | — | 0001086364-12-002574 | Jun 8, 2012 | — |
| SC 13G/A | DISCLOSURE DOCUMENT | 0000902219-12-000535 | May 10, 2012 | — |
| SC 13G/A | DISCLOSURE DOCUMENT | 0000902219-12-000325 | Feb 14, 2012 | — |
| SC 13G/A | — | 0001086364-12-001856 | Feb 13, 2012 | — |
| SC 13G/A | SCHEDULE 13G AMENDMENT | 0001144204-12-005768 | Feb 3, 2012 | — |
| SC 13G/A | SEC FILING | 0000902219-11-000759 | Feb 14, 2011 | — |
| SC 13G/A | — | 0001144204-11-007263 | Feb 10, 2011 | — |
| SC 13G/A | SEC FILING | 0000902219-10-000754 | Feb 12, 2010 | — |
| SC 13G/A | NOVAVAX | 0000909012-10-000053 | Feb 9, 2010 | — |
| SC 13G/A | AMENDMENT 4 TO FORM 13G | 0000728889-10-000325 | Feb 3, 2010 | — |
| SC 13G/A | SEC FILING | 0000902219-09-001137 | Jun 10, 2009 | — |
| SC 13G/A | SCHEDULE 13G/A - NOVAVAX, INC. | 0000894579-09-000132 | Feb 13, 2009 | — |
| SC 13G/A | AMENDMENT TO SCHEDULE 13G | 0000950134-09-002475 | Feb 11, 2009 | — |
| SC 13G/A | AMENDMENT 3 TO SCHEDULE 13G | 0000728889-09-000154 | Jan 27, 2009 | — |
| SC 13G/A | AMENDMENT TO SCHEDULE 13G | 0000950134-08-002546 | Feb 14, 2008 | — |